AdisInsight helps users to stay at the forefront of research by providing the most compelling current evidence on drug treatments being developed worldwide: an integrated database of reports authored by Springer editors on drugs in development, clinical trials, drug safety, company deals and patents.
Content is sourced from information that is publicly available through journals (all publishers), conferences, media releases, company websites, internet trial registries, SEC filings and, investor pages. Commercial, biomarker, and patent content is provided through partnerships with Credit Suisse, Amplion and Think Biotech.
Some use cases, however, cannot be satisfied with the internet platform (adisinsight.springer.com), requiring direct access to AdisInsight content. To meet such needs, we now provide two solutions to directly access AdisInsight content: Data Feed & API.